10 min read
Monthly FDA Guidance and Regulatory News Review - May 2026
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running or just need medical writing or biostatistical support for your programs - Veristat can help. We provide impactful solutions on both a full-service or functional service basis.
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes. Or learn more about our capabilities.

Website: https://www.diaglobal.org/en/flagship/dia-2020/about/conference
10 min read
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...
7 min read
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...